129 related articles for article (PubMed ID: 38112973)
21. FebriDx
Shirley M
Mol Diagn Ther; 2019 Dec; 23(6):803-809. PubMed ID: 31691924
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of C-reactive protein and myxovirus resistance protein A to guide the rational use of antibiotics among acute febrile adult patients in Northwest Ethiopia.
Akelew Y; Derbew A; Lemma M; Negash M; Bewket G; Belay G; Pollmann J; Adriaensen W; Adane A; Mohammed R; van Griensven J; Cnops L
Int J Infect Dis; 2020 Dec; 101():276-282. PubMed ID: 33002622
[TBL] [Abstract][Full Text] [Related]
23. The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.
Glymph S; Mandal S; Knowell AE; Abebe F; Chaudhary J
Infect Genet Evol; 2013 Jun; 16():186-90. PubMed ID: 23438650
[TBL] [Abstract][Full Text] [Related]
24. Using the kinetics of C-reactive protein response to improve the differential diagnosis between acute bacterial and viral infections.
Coster D; Wasserman A; Fisher E; Rogowski O; Zeltser D; Shapira I; Bernstein D; Meilik A; Raykhshtat E; Halpern P; Berliner S; Shenhar-Tsarfaty S; Shamir R
Infection; 2020 Apr; 48(2):241-248. PubMed ID: 31873850
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein in viral and bacterial respiratory infection in children.
Korppi M; Kröger L
Scand J Infect Dis; 1993; 25(2):207-13. PubMed ID: 8511515
[TBL] [Abstract][Full Text] [Related]
26. Rational design of MIPs for the detection of Myxovirus resistance protein A (MxA), a biomarker for viral infection.
Rajpal S; Mizaikoff B; Mishra P
Int J Biol Macromol; 2024 May; 266(Pt 1):131101. PubMed ID: 38547939
[TBL] [Abstract][Full Text] [Related]
27. The MxA protein levels in whole blood lysates of patients with various viral infections.
Chieux V; Hober D; Harvey J; Lion G; Lucidarme D; Forzy G; Duhamel M; Cousin J; Ducoulombier H; Wattré P
J Virol Methods; 1998 Feb; 70(2):183-91. PubMed ID: 9562412
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of IL-6, CRP, WBC, and absolute neutrophil count to predict serious bacterial infection in febrile infants.
Zarkesh M; Sedaghat F; Heidarzadeh A; Tabrizi M; Bolooki-Moghadam K; Ghesmati S
Acta Med Iran; 2015 Jul; 53(7):408-11. PubMed ID: 26520627
[TBL] [Abstract][Full Text] [Related]
30. Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
Brendish NJ; Davis C; Chapman ME; Borca F; Waddington D; Hill C; White N; Clark TW
J Infect; 2024 Jan; 88(1):41-47. PubMed ID: 37977337
[TBL] [Abstract][Full Text] [Related]
31. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
33. New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection.
Kawamura M; Kusano A; Furuya A; Hanai N; Tanigaki H; Tomita A; Horiguchi A; Nagata K; Itazawa T; Adachi Y; Okabe Y; Miyawaki T; Kohno H
J Clin Lab Anal; 2012 May; 26(3):174-83. PubMed ID: 22628233
[TBL] [Abstract][Full Text] [Related]
34. Association of human myxovirus resistance protein A with severity of COVID-19.
Lehtinen O; Broman N; Waris M; Vuorinen T; Peltola V; Löyttyniemi E; Oksi J; Feuth T
BMC Infect Dis; 2022 Sep; 22(1):755. PubMed ID: 36171547
[TBL] [Abstract][Full Text] [Related]
35. A two-transcript biomarker of host classifier genes for discrimination of bacterial from viral infection in acute febrile illness: a multicentre discovery and validation study.
Xu N; Hao F; Dong X; Yao Y; Guan Y; Yang L; Chen F; Zheng F; Li Q; Liu W; Zhao C; Li W; Palavecino E; Wang W; Wang G
Lancet Digit Health; 2021 Aug; 3(8):e507-e516. PubMed ID: 34325854
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
[TBL] [Abstract][Full Text] [Related]
37. Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States.
Dick K; Schneider J
J Health Econ Outcomes Res; 2021; 8(2):56-62. PubMed ID: 34703832
[No Abstract] [Full Text] [Related]
38. Increased levels of antiviral MxA protein in peripheral blood of patients with a chronic disease of unknown etiology.
Chieux V; Chehadeh W; Hautecoeur P; Harvey J; Wattré P; Hober D
J Med Virol; 2001 Oct; 65(2):301-8. PubMed ID: 11536237
[TBL] [Abstract][Full Text] [Related]
39. A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients.
Safarika A; Wacker JW; Katsaros K; Solomonidi N; Giannikopoulos G; Kotsaki A; Koutelidakis IM; Coyle SM; Cheng HK; Liesenfeld O; Sweeney TE; Giamarellos-Bourboulis EJ
Intensive Care Med Exp; 2021 Jun; 9(1):31. PubMed ID: 34142256
[TBL] [Abstract][Full Text] [Related]
40. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19).
Karim N; Ashraf MZ; Naeem M; Anwar T; Aung H; Mallik S; Avraam E; Kiran S; Bandapaati S; Khan F; Tsaknis G; Reddy R
Int J Clin Pract; 2021 Mar; 75(3):e13702. PubMed ID: 32896946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
